ArticleExperimental and therapeutic medicine2020

Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway.

Sen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.